|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 23, 2017 ) Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. Non-ulcer dyspepsia is also called functional dyspepsia or non-ulcer stomach pain. Signs and symptoms include burning sensation or discomfort in your upper abdomen or lower chest sometimes relieved by food or antacids bloating belching and nausea. The predisposing factors include consuming excessive amounts of caffeine or alcohol smoking and taking certain medications especially certain over-the-counter pain relievers such as aspirin and ibuprofen (advil motrin others) which can cause stomach problems. Treatment includes medications to reduce acid production antibiotics and low-dose antidepressants.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Functional (Non Ulcer) Dyspepsia-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia (Gastrointestinal) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.
The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Phase III Phase II Phase I and Preclinical stages are 2 2 3 and 1 respectively. Similarly the Universities portfolio in Discovery stages comprises 1 molecules respectively.
Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/functional-dyspepsia-pipeline-review-h2-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Functional (Non Ulcer) Dyspepsia (Gastrointestinal) .
- The pipeline guide reviews pipeline therapeutics for Functional (Non Ulcer) Dyspepsia (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Functional (Non Ulcer) Dyspepsia (Gastrointestinal) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Functional (Non Ulcer) Dyspepsia (Gastrointestinal) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Functional (Non Ulcer) Dyspepsia (Gastrointestinal)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881440/sample
Reasons to buy
- Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Functional (Non Ulcer) Dyspepsia (Gastrointestinal) .
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Abide Therapeutics Inc
Daewoong Pharmaceutical Co Ltd
RaQualia Pharma Inc
Yuhan Corp
Zeria Pharmaceutical Co Ltd
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001881440/discount
List of Tables
Number of Products under Development for Functional (Non Ulcer) Dyspepsia H2 2017
Number of Products under Development by Companies H2 2017
Number of Products under Development by Universities/Institutes H2 2017
Products under Development by Companies H2 2017
Products under Development by Universities/Institutes H2 2017
Number of Products by Stage and Target H2 2017
Number of Products by Stage and Mechanism of Action H2 2017
Number of Products by Stage and Route of Administration H2 2017
Number of Products by Stage and Molecule Type H2 2017
Functional (Non Ulcer) Dyspepsia-Pipeline by Abide Therapeutics Inc H2 2017
Functional (Non Ulcer) Dyspepsia-Pipeline by Daewoong Pharmaceutical Co Ltd H2 2017
Functional (Non Ulcer) Dyspepsia-Pipeline by RaQualia Pharma Inc H2 2017
Functional (Non Ulcer) Dyspepsia-Pipeline by Yuhan Corp H2 2017
Functional (Non Ulcer) Dyspepsia-Pipeline by Zeria Pharmaceutical Co Ltd H2 2017
Functional (Non Ulcer) Dyspepsia-Dormant Projects H2 2017
Functional (Non Ulcer) Dyspepsia-Discontinued Products H2 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001881440/buy/2000
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
